LEADER 02611nam  2200613 a 450 
001 9910457246603321
005 20200520144314.0
010   $a1-283-21345-1
010   $a9786613213457
010   $a0-309-21222-7
035   $a(CKB)2550000000043073
035   $a(EBL)3378800
035   $a(SSID)ssj0000537170
035   $a(PQKBManifestationID)11352570
035   $a(PQKBTitleCode)TC0000537170
035   $a(PQKBWorkID)10553842
035   $a(PQKB)11052430
035   $a(MiAaPQ)EBC3378800
035   $a(Au-PeEL)EBL3378800
035   $a(CaPaEBR)ebr10488621
035   $a(CaONFJC)MIL321345
035   $a(OCoLC)923283605
035   $a(EXLCZ)992550000000043073
100   $a20110827d2011      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aGlutamate-related biomarkers in drug development for disorders of the nervous system$b[electronic resource] $eworkshop summary /$fDiana E. Pankevich, Miriam Davis, and Bruce M. Altevogt, rapporteurs ; Forum on Neuroscience and Nervous System Disorders, Board of Population Health and Public Health Practice, Institute of Medicine of the National Academies
210   $aWashington, D.C. $cNational Academies Press$d2011
215   $a1 online resource (74 p.)
300   $aDescription based upon print version of record.
311   $a0-309-21221-9 
320   $aIncludes bibliographical references and index.
327   $a""Front Matter""; ""Reviewers""; ""Contents""; ""1 Introduction""; ""2 Overview of the Glutamatergic System""; ""3 Glutamate Biomarkers""; ""4 Treatment Implications of Biomarkers""; ""5 Challenges and Opportunities""; ""Appendix A: References""; ""Appendix B: Registered Attendees""; ""Appendix C: Agenda""
606   $aGlutamic acid$xPharmacokinetics
606   $aCentral nervous system$xDiseases
608   $aElectronic books.
615  0$aGlutamic acid$xPharmacokinetics.
615  0$aCentral nervous system$xDiseases.
676   $a616.8061
701   $aPankevich$b Diana E$0856947
701   $aDavis$b Miriam$0856948
701   $aAltevogt$b Bruce M$0856949
712 02$aInstitute of Medicine (U.S.).$bForum on Neuroscience and Nervous System Disorders.
712 02$aInstitute of Medicine (U.S.).$bBoard of Population Health and Public Health Practice.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910457246603321
996   $aGlutamate-related biomarkers in drug development for disorders of the nervous system$91913742
997   $aUNINA